![New data: COVID booster shots likely provide increased, broad protection against new Omicron variant in human patients with cancer New data: COVID booster shots likely provide increased, broad protection against new Omicron variant in human patients with cancer](https://cancer.osu.edu/-/media/images/shared/media-room/cancer/press-releases/2021/december/an-illustration-of-coronavirus.jpg)
New data: COVID booster shots likely provide increased, broad protection against new Omicron variant in human patients with cancer
![Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/080f25e3-04ea-438a-a5e1-df19d5ad778d/gr1_lrg.jpg)
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology
![Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report](https://www.frontiersin.org/files/Articles/798095/fmed-08-798095-HTML/image_m/fmed-08-798095-g001.jpg)
Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
![New COVID-19 vaccine booster guidelines for cancer patients | Roswell Park Comprehensive Cancer Center - Buffalo, NY New COVID-19 vaccine booster guidelines for cancer patients | Roswell Park Comprehensive Cancer Center - Buffalo, NY](http://www.roswellpark.org/sites/default/files/2020-12/mccarthy_covid_vaccine.jpeg)
New COVID-19 vaccine booster guidelines for cancer patients | Roswell Park Comprehensive Cancer Center - Buffalo, NY
![Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination | University of Oxford Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/covid-research-header-1200575.jpg?itok=Ea8s_w4n)
Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination | University of Oxford
![2023-2024 COVID-19 Vaccine for People with Cancer & Others with Weakened Immune Systems | Memorial Sloan Kettering Cancer Center 2023-2024 COVID-19 Vaccine for People with Cancer & Others with Weakened Immune Systems | Memorial Sloan Kettering Cancer Center](https://www.mskcc.org/sites/default/files/styles/large/public/node/230449/3x2/bic_210325_289_1200x800.jpg)
2023-2024 COVID-19 Vaccine for People with Cancer & Others with Weakened Immune Systems | Memorial Sloan Kettering Cancer Center
![New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose | Leukemia and Lymphoma Society New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose | Leukemia and Lymphoma Society](https://www.lls.org/sites/default/files/styles/image_component/public/2021-09/CovidVaccine_ThirdDose_PieChart_9_21.jpg?itok=CeWmzusH)
New Study Shows Most Blood Cancer Patients Benefit from an Additional COVID-19 Vaccine Dose | Leukemia and Lymphoma Society
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine is Safe but 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies | Leukemia and Lymphoma Society
![Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study - The Lancet Oncology Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study - The Lancet Oncology](https://www.thelancet.com/cms/asset/49ee8a10-3bb7-4f01-ae9f-1a4c8e7c9ab6/gr1.jpg)
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study - The Lancet Oncology
![Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer - The Lancet Oncology Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer - The Lancet Oncology](https://www.thelancet.com/cms/attachment/178b68a4-3515-4ce5-8002-691edfab300f/gr1_lrg.jpg)